Whole exome sequencing (WES) and whole genome sequencing (WGS) both get marketed as "comprehensive" genetic tests, and the marketing isn't entirely wrong — but the two approaches are reading fundamentally different amounts of your DNA. WES targets only the exons: the roughly 1.5-2% of your genome that directly codes for proteins. WGS reads essentially the entire 3-billion-base-pair genome, including introns, regulatory regions, and the vast non-coding majority that WES simply doesn't capture at all.
Why Exomes Became Popular in the First Place
The logic behind exome sequencing made sense for a long time: the large majority of known disease-causing mutations catalogued in major variant databases occur in protein-coding regions, and sequencing a smaller target is cheaper and generates far less data to store and analyze. For years, that trade-off was the practical, cost-effective choice for clinical diagnostic labs working with limited budgets, and it's still a reasonable option in specific clinical contexts today.
| Whole Exome Sequencing | Whole Genome Sequencing | |
|---|---|---|
| Coverage | ~1.5-2% (protein-coding exons only) | ~100% (coding + non-coding + mitochondrial DNA) |
| Structural variant / CNV detection | Poor — most extend beyond targeted regions | Reliable |
| Regulatory / non-coding variant detection | Not captured | Captured |
| Coverage uniformity | More variable, capture-method dependent | More uniform |
The Part That Surprises People: WES Isn't Even Perfectly Comprehensive Within Its Own Target
Here's a detail most comparisons skip: even within the regions WES is specifically designed to capture, it doesn't do so perfectly. A well-cited comparison study found that at comparable sequencing depth, WGS actually detected more real coding-region variants than WES did within the exact same targeted areas, partly due to more uniform coverage and fewer capture-related biases. In that study, WES also produced a meaningfully higher false-positive rate for detected variants than WGS did. And WES performs particularly poorly at one specific job: detecting structural variants and copy-number variations, most of which physically extend beyond the narrow regions exome capture kits are designed to target in the first place — meaning WES can miss entire categories of clinically relevant mutations by design, not just by omission of "extra" DNA.
WES isn't a smaller, cheaper version of the same test as WGS — it's a fundamentally narrower lens. It works well for the specific, well-catalogued coding mutations it was built to find, but it structurally cannot see most non-coding variation, most structural variants, and mitochondrial DNA, all of which whole genome sequencing captures by default.
Why Non-Coding DNA Matters More Than the Old "Junk DNA" Framing Suggested
Non-coding DNA was once dismissively called "junk DNA," but that framing is outdated. Much of it contains regulatory elements — sequences that control when, where, and how much a gene gets expressed, rather than coding for a protein directly. Mutations in these regulatory regions can meaningfully affect health without ever touching a protein-coding exon, which is exactly the category of variation WES is structurally blind to and WGS captures as a matter of course.
Which One Should You Choose?
For most consumers seeking the fullest picture of their genetics — carrier status, structural variants, pharmacogenomics, and future-proofed raw data that can be reanalyzed as science advances — whole genome sequencing is the stronger long-term choice, and pricing has come down enough that the cost gap with exome sequencing has narrowed considerably. WES still has a specific, legitimate role in some clinical diagnostic workflows focused narrowly on known coding-region conditions, but as a general-purpose personal genetics test, it's the narrower of the two tools by design.
Get the Whole Picture, Not Just 1.5% of It
Dante Labs' whole genome sequencing reads your complete genome — coding, non-coding, and mitochondrial DNA — in one test you own. Use code GENOME for 10% off.
Get Sequenced with Dante Labs → 10% off with code GENOMEFor more on how raw sequencing data is structured, see our FASTQ, BAM, and VCF explainer. And for how structural variants specifically differ from the single-letter changes most people picture, see our guide to structural variants and CNVs.